| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,673 |
5,077 |
$415K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,302 |
2,238 |
$201K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,788 |
1,733 |
$127K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,208 |
2,936 |
$87K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
887 |
828 |
$41K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,020 |
844 |
$11K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
211 |
200 |
$11K |
| 87428 |
|
351 |
339 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,241 |
1,173 |
$8K |
| 87400 |
|
1,040 |
489 |
$5K |
| 99000 |
|
253 |
235 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
72 |
68 |
$436.46 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$110.00 |